These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11222452)

  • 1. Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a UK population.
    Hill ME; Creed GA; McMullan TF; Tyers AG; Hilton-Jones D; Robinson DO; Hammans SR
    Brain; 2001 Mar; 124(Pt 3):522-6. PubMed ID: 11222452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].
    Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B
    Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GCG repeats and phenotype in oculopharyngeal muscular dystrophy.
    Müller T; Schröder R; Zierz S
    Muscle Nerve; 2001 Jan; 24(1):120-2. PubMed ID: 11150975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy.
    Mirabella M; Silvestri G; de Rosa G; Di Giovanni S; Di Muzio A; Uncini A; Tonali P; Servidei S
    Neurology; 2000 Feb; 54(3):608-14. PubMed ID: 10680791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PABP2 polyalanine tract expansion causes intranuclear inclusions in oculopharyngeal muscular dystrophy.
    Shanmugam V; Dion P; Rochefort D; Laganière J; Brais B; Rouleau GA
    Ann Neurol; 2000 Nov; 48(5):798-802. PubMed ID: 11079546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unequal crossing-over in unique PABP2 mutations in Japanese patients: a possible cause of oculopharyngeal muscular dystrophy.
    Nakamoto M; Nakano S; Kawashima S; Ihara M; Nishimura Y; Shinde A; Kakizuka A
    Arch Neurol; 2002 Mar; 59(3):474-7. PubMed ID: 11890856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of oculopharyngeal muscular dystrophy in Hispanic American families.
    Grewal RP; Karkera JD; Grewal RK; Detera-Wadleigh SD
    Arch Neurol; 1999 Nov; 56(11):1378-81. PubMed ID: 10555658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.
    Brais B; Bouchard JP; Xie YG; Rochefort DL; Chrétien N; Tomé FM; Lafrenière RG; Rommens JM; Uyama E; Nohira O; Blumen S; Korczyn AD; Heutink P; Mathieu J; Duranceau A; Codère F; Fardeau M; Rouleau GA
    Nat Genet; 1998 Feb; 18(2):164-7. PubMed ID: 9462747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oculopharyngeal muscular dystrophy in a Japanese family with a short GCG expansion (GCG)(11) in PABP2 gene.
    Nagashima T; Kato H; Kase M; Maguchi S; Mizutani Y; Matsuda K; Chuma T; Mano Y; Goto Y; Minami N; Nonaka I; Nagashima K
    Neuromuscul Disord; 2000 Mar; 10(3):173-7. PubMed ID: 10734263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
    Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
    J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oculopharyngeal muscular dystrophy.
    Brais B; Rouleau GA; Bouchard JP; Fardeau M; Tomé FM
    Semin Neurol; 1999; 19(1):59-66. PubMed ID: 10711989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A late-onset case of oculopharyngeal muscular dystrophy carrying a (GCG)8 repeat expansion in the PAPBN1 gene].
    Tokutake T; Ikeuchi T; Tanaka K; Onodera O; Nishizawa M
    Rinsho Shinkeigaku; 2005 Jun; 45(6):437-40. PubMed ID: 16022469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oculopharyngeal muscular dystrophy in Hispanic New Mexicans.
    Becher MW; Morrison L; Davis LE; Maki WC; King MK; Bicknell JM; Reinert BL; Bartolo C; Bear DG
    JAMA; 2001 Nov; 286(19):2437-40. PubMed ID: 11712939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene.
    Blumen SC; Korczyn AD; Lavoie H; Medynski S; Chapman J; Asherov A; Nisipeanu P; Inzelberg R; Carasso RL; Bouchard JP; Tomé FM; Rouleau GA; Brais B
    Neurology; 2000 Nov; 55(9):1267-70. PubMed ID: 11087766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy.
    Uyama E; Tsukahara T; Goto K; Kurano Y; Ogawa M; Kim YJ; Uchino M; Arahata K
    Muscle Nerve; 2000 Oct; 23(10):1549-54. PubMed ID: 11003790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oculopharyngeal muscular dystrophy among Bulgarian Jews: a new cluster?
    Blumen SC; Kesler A; Dabby R; Shalev S; Khayat M; Almog Y; Zoldan J; Benninger F; Drory VE; Gurevich M; Sadeh M; Brais B; Braverman I
    Isr Med Assoc J; 2013 Dec; 15(12):748-52. PubMed ID: 24449978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual triplet expansion associated with neurogenic changes in a family with oculopharyngeal muscular dystrophy.
    Schober R; Kress W; Grahmann F; Kellermann S; Baum P; Günzel S; Wagner A
    Neuropathology; 2001 Mar; 21(1):45-52. PubMed ID: 11304042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oculopharyngeal muscular dystrophy: phenotypic and genotypic characteristics of 9 Polish patients.
    Nadaj-Pakleza A; Richard P; Lusakowska A; Gajewska J; Jamrozik Z; Kostera-Pruszczyk A; Kwieciński H; Kamińska A
    Neurol Neurochir Pol; 2009; 43(2):113-20. PubMed ID: 19484687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique PABP2 mutations in "Cajuns" suggest multiple founders of oculopharyngeal muscular dystrophy in populations with French ancestry.
    Scacheri PC; Garcia C; Hébert R; Hoffman EP
    Am J Med Genet; 1999 Oct; 86(5):477-81. PubMed ID: 10508991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
    Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.